CLSH
Price
$0.04
Change
-$0.00 (-0.00%)
Updated
Jul 3 closing price
Capitalization
5.94M
EAPIF
Price
$3.09
Change
-$0.56 (-15.34%)
Updated
Aug 6 closing price
Capitalization
345.75M
Interact to see
Advertisement

CLSH vs EAPIF

Header iconCLSH vs EAPIF Comparison
Open Charts CLSH vs EAPIFBanner chart's image
CLS Holdings USA
Price$0.04
Change-$0.00 (-0.00%)
Volume$26.23K
Capitalization5.94M
EUROAPI SA
Price$3.09
Change-$0.56 (-15.34%)
Volume$292
Capitalization345.75M
CLSH vs EAPIF Comparison Chart in %
Loading...
CLSH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
EAPIF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CLSH vs. EAPIF commentary
Aug 17, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CLSH is a Hold and EAPIF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 17, 2025
Stock price -- (CLSH: $0.04 vs. EAPIF: $3.09)
Brand notoriety: CLSH and EAPIF are both not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: CLSH: 66% vs. EAPIF: 20%
Market capitalization -- CLSH: $5.94M vs. EAPIF: $345.75M
CLSH [@Pharmaceuticals: Generic] is valued at $5.94M. EAPIF’s [@Pharmaceuticals: Generic] market capitalization is $345.75M. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $68.3B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $3.75B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CLSH’s FA Score shows that 1 FA rating(s) are green whileEAPIF’s FA Score has 0 green FA rating(s).

  • CLSH’s FA Score: 1 green, 4 red.
  • EAPIF’s FA Score: 0 green, 5 red.
According to our system of comparison, CLSH is a better buy in the long-term than EAPIF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CLSH’s TA Score shows that 2 TA indicator(s) are bullish while EAPIF’s TA Score has 2 bullish TA indicator(s).

  • CLSH’s TA Score: 2 bullish, 4 bearish.
  • EAPIF’s TA Score: 2 bullish, 5 bearish.
According to our system of comparison, EAPIF is a better buy in the short-term than CLSH.

Price Growth

CLSH (@Pharmaceuticals: Generic) experienced а 0.00% price change this week, while EAPIF (@Pharmaceuticals: Generic) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was +4.25%. For the same industry, the average monthly price growth was +10.98%, and the average quarterly price growth was +78.05%.

Industries' Descriptions

@Pharmaceuticals: Generic (+4.25% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
EAPIF($346M) has a higher market cap than CLSH($5.94M). EAPIF has higher P/E ratio than CLSH: EAPIF (7.92) vs CLSH (3.60). CLSH YTD gains are higher at: 18.197 vs. EAPIF (2.890). CLSH has higher annual earnings (EBITDA): 4.72M vs. EAPIF (-34.7M). EAPIF has more cash in the bank: 73M vs. CLSH (221K). CLSH has less debt than EAPIF: CLSH (4.84M) vs EAPIF (69.1M). EAPIF has higher revenues than CLSH: EAPIF (919M) vs CLSH (17.5M).
CLSHEAPIFCLSH / EAPIF
Capitalization5.94M346M2%
EBITDA4.72M-34.7M-14%
Gain YTD18.1972.890630%
P/E Ratio3.607.9246%
Revenue17.5M919M2%
Total Cash221K73M0%
Total Debt4.84M69.1M7%
FUNDAMENTALS RATINGS
CLSH: Fundamental Ratings
CLSH
OUTLOOK RATING
1..100
44
VALUATION
overvalued / fair valued / undervalued
1..100
45
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
51
P/E GROWTH RATING
1..100
18
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CLSHEAPIF
RSI
ODDS (%)
N/A
Bullish Trend 2 days ago
42%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
39%
Momentum
ODDS (%)
Bullish Trend 5 days ago
87%
Bearish Trend 2 days ago
26%
MACD
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 2 days ago
33%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
36%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
80%
Bearish Trend 2 days ago
22%
Advances
ODDS (%)
N/A
N/A
Declines
ODDS (%)
N/A
N/A
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
N/A
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
31%
View a ticker or compare two or three
Interact to see
Advertisement
CLSH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
EAPIF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
DCGO1.62-0.01
-0.61%
DocGo
GYRE8.14-0.08
-0.97%
Gyre Therapeutics
IR78.32-1.88
-2.34%
Ingersoll Rand
ATMU43.45-1.73
-3.83%
Atmus Filtration Technologies
TKLF3.53-0.26
-6.81%
Tokyo Lifestyle Co Ltd

CLSH and

Correlation & Price change

A.I.dvisor tells us that CLSH and TSNDF have been poorly correlated (+14% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CLSH and TSNDF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CLSH
1D Price
Change %
CLSH100%
N/A
TSNDF - CLSH
14%
Poorly correlated
+1.10%
HLNCF - CLSH
6%
Poorly correlated
+2.77%
EAPIF - CLSH
4%
Poorly correlated
N/A
ESAIY - CLSH
1%
Poorly correlated
+2.73%
SHPH - CLSH
1%
Poorly correlated
-5.14%
More

EAPIF and

Correlation & Price change

A.I.dvisor tells us that EAPIF and HLN have been poorly correlated (+14% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that EAPIF and HLN's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To EAPIF
1D Price
Change %
EAPIF100%
N/A
HLN - EAPIF
14%
Poorly correlated
+0.09%
HLNCF - EAPIF
11%
Poorly correlated
+2.77%
IXHL - EAPIF
7%
Poorly correlated
-3.77%
STEK - EAPIF
6%
Poorly correlated
+0.55%
CLSH - EAPIF
4%
Poorly correlated
N/A
More